Opioid-Withdrawal 'Aids' Warrant Immediate FDA, FTC Action – CSPI
This article was originally published in The Rose Sheet
Executive Summary
FDA and the Federal Trade Commission should bring immediate enforcement action against marketers of non-kratom dietary supplements promoted as opioid-withdrawal aids, says the Center for Science in the Public Interest in letters to the agency and commission Dec. 8. The nonprofit identified eight supplement products making opioid-withdrawal claims without sufficient science to support the statements.